In a recent decision, the Centers for Medicare and Medicaid Services have declined a proposal to expand Medicare coverage for ...
The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part ...
A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro — that have ...
CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...
The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...
President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...
The Centers for Medicare & Medicaid Services said on Friday that it did not move forward with a proposal put forth by the ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...